Star Biosciences is a subsidiary of Star Health Network, Inc. Star Biosciences is focused on oncology and serves Clinician, patients, academic researchers and drug developers with comprehensive repertoire of oncology testing - from IHC to molecular diagnostics to next generations sequencing. Star Biosciences supports patients in India- SE-Asia- Africa, which accounts for more than 50% of the world’s cancer population. Through clinical assays, the company identifies the molecular alterations in a patient's cancer and matches them with relevant targeted therapies and clinical trials. Star Biosciences also supports academic researchers and drug developers with Bio-Marker Discovery, Clinical Trials patient identification and operations and Real world Evidence (RWE) data, all services intended to help advance the science of molecular medicine in cancer.